Participants 61 117 4
children and adolescents with autism spectrum disorders:
Participants 486 542 3
children and adolescents with autism spectrum disorders.
Participants 634 724 6
children and adolescents with autism spectrum disorders and prominent repetitive behavior.
Participants 855 1038 7
A total of 149 children and adolescents 5 to 17 years of age (mean [SD] age, 9.4 [3.1] years) from 6 academic centers were randomly assigned to citalopram (n = 73) or placebo (n = 76)
Participants 1040 1419 4
Participants had autistic disorder, Asperger syndrome, or pervasive developmental disorder, not otherwise specified; had illness severity ratings that were moderate or more than moderate on the Clinical Global Impression-Severity scale; and scored moderate or more than moderate on compulsive behaviors measured with the modified Children's Yale-Brown Obsessive-Compulsive Scale.
Participants 2916 2972 3
children and adolescents with autism spectrum disorders.
